SWTX
$35.59
Revenue | $49.3Mn |
Net Profits | $-53.53Mn |
Net Profit Margins | -108.58% |
Springworks Therapeutics Inc’s revenue jumped 782.58% since last year same period to $49.3Mn in the Q3 2024. On a quarterly growth basis, Springworks Therapeutics Inc has generated -17.46% fall in its revenue since last 3-months.
Springworks Therapeutics Inc’s net profit jumped 32.61% since last year same period to $-53.53Mn in the Q3 2024. On a quarterly growth basis, Springworks Therapeutics Inc has generated -34.1% fall in its net profits since last 3-months.
Springworks Therapeutics Inc’s net profit margin jumped 92.36% since last year same period to -108.58% in the Q3 2024. On a quarterly growth basis, Springworks Therapeutics Inc has generated -62.47% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.75 |
EPS Estimate Current Year | -0.75 |
Springworks Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.75 - a 32.43% jump from last quarter’s estimates.
Springworks Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.75.
Earning Per Share (EPS) | -0.72 |
Springworks Therapeutics Inc’s earning per share (EPS) jumped 43.24% since last year same period to -0.72 in the Q3 2024. This indicates that the Springworks Therapeutics Inc has generated 43.24% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-11-12 | -0.75 | -0.72 | 3.89% |
2024-08-07 | -1.11 | -0.54 | 51.35% |
2024-05-02 | -1.17 | -1.18 | -0.85% |